Engineering hypoxia-specific core–shell nanotherapeutics: A sequential strategy for amplified multimodal synergistic breast cancer treatment
- 10 May 2025
- journal article
- Published by Elsevier in Journal of Colloid and Interface Science
- Vol. 696, 137854
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (52173295, 52472291, 52202357)
This publication has 69 references indexed in Scilit:
- Narrow Bandgap Schottky Heterojunction Sonosensitizer with High Electron–Hole Separation Boosted Sonodynamic Therapy in Bladder CancerAdvanced Materials, 2024
- Oxygen‐Independent Synchronized ROS Generation and Hypoxia Prodrug Activation with Z‐Scheme Heterostructure SonosensitizerAdvanced Materials, 2023
- DNA‐Templated Ag@Pd Nanoclusters for NIR‐II Photoacoustic Imaging‐Guided Photothermal‐Augmented Nanocatalytic TherapyAdvanced Healthcare Materials, 2023
- A Multimodal Therapeutic Nanoplatform Overcoming Tumor Hypoxia Heterogeneity for Improved Tumor ChemoradiotherapyAdvanced Functional Materials, 2022
- Inorganic Nanomaterials with Intrinsic Singlet Oxygen Generation for Photodynamic TherapyAdvanced Science, 2021
- Polyphenol‐Containing Nanoparticles: Synthesis, Properties, and Therapeutic DeliveryAdvanced Materials, 2021
- Nanocatalytic Theranostics with Glutathione Depletion and Enhanced Reactive Oxygen Species Generation for Efficient Cancer TherapyAdvanced Materials, 2021
- In Situ Polymerized Hollow Mesoporous Organosilica Biocatalysis Nanoreactor for Enhancing ROS‐Mediated Anticancer TherapyAdvanced Functional Materials, 2019
- Hyaluronic Acid–Based Activatable Nanomaterials for Stimuli‐Responsive Imaging and Therapeutics: Beyond CD44‐Mediated Drug DeliveryAdvanced Materials, 2019
- Physical, Chemical, and Biological Structures based on ROS‐Sensitive Moieties that are Able to Respond to Oxidative MicroenvironmentsAdvanced Materials, 2016